Nurix Obtains $17,033,334 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=605cea9e-cb0a-41b5-a399-c49db62b7d87
Date
9/18/2015
Company Name
Nurix
Mailing Address
1700 Owens Street San Francisco, CA 94158 USA
Company Description
The company is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.
Website
http://www.nurix-inc.com
Transaction Type
Venture Equity
Transaction Amount
$17,033,334
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds are to be used for working capital. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
M&A Terms
Venture Investor
Undisclosed